Evaluation of the Role of Inflammation in Chronic Airways Disease (ERICA)


At a Glance
  • Status: Completed Consortium
  • Year Launched: 2010
  • Initiating Organization: Royal Brompton Hospital
  • Initiator Type: Academia
  • Disease focus:
    Copd

Abstract

The Evaluation of the Role of Inflammation in non-pulmonary disease manifestations in Chronic Airways project (ERICA), funded by the Technology Strategy Board, aims to take research into chronic obstructive pulmonary disease (COPD) forward by studying the effects of inflammation in disease. The objective of the ERICA project is to relate systemic inflammation, defined by elevated fibrinogen, to non-pulmonary disease manifestations in COPD identified by candidate bedside biomarkers of cardiovascular and muscle function.

Mission

The overarching aim of ERICA is to relate systemic inflammation, defined by an elevated fibrinogen, to non-pulmonary disease manifestations in COPD identified by candidate bedside biomarkers of cardiovascular and muscle function. The project will extend the understanding of these biomarkers through cross-sectional evaluation of subjects recruited from existing well-characterized cohorts in the United Kingdom and using experimental medicine hypothesis-testing trials in patients with evidence of systemic inflammation. The impact of this work will be twofold: (i) generating evidence on stratification and efficacy biomarkers to facilitate the design of smaller, more efficient Phase I-III clinical trials of medicines targeting inflammatory COPD subsets, thereby reducing attrition of new medicines; and (ii) supporting the development of two specific therapies, thus validating a stratified medicine approach.

Financing

Funded by the Technology Strategy Board

http://cctu.medschl.cam.ac.uk/erica

Sponsors & Partners

GlaxoSmithKline

The University of Nottingham

Cardiff University

The Royal Brompton Hospital (Imperial College London)

Cambridge University

The University of Edinburgh


Last Updated: 04/15/2016

The Consortia-pedia Catalogue is a living resource, and we are always adding new consortia. Provide information here about your collaboration to apply to be included in the Catalogue.

All the information contained in the Consortia-pedia was collected from publically available sources. Decisions to include or exclude a particular listing from Consortia-pedia were also made on the basis of publically available information and the criteria outlined in the FAQs. This site is intended to be an objective resource for the community, and inclusion does not constitute or imply endorsement, recommendation, or approval by FasterCures or the Milken Institute.